Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
| Autor: | Ponikowski, Piotr van Veldhuisen, Dirk J. Comin-Colet, Josep and Ertl, Georg Komajda, Michel Mareev, Viacheslav McDonagh, Theresa Parkhomenko, Alexander Tavazzi, Luigi Levesque, Victoria Mori, Claudio Roubert, Bernard Filippatos, Gerasimos Ruschitzka, Frank Anker, Stefan D. CONFIRM-HF Investigators |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Popis: | Aim The aim of this study was to evaluate the benefits and safety of long-term i.v. iron therapy in iron-deficient patients with heart failure (HF). Methods and results CONFIRM-HF was a multi-centre, double-blind, placebo-controlled trial that enrolled 304 ambulatory symptomatic HF patients with left ventricular ejection fraction |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|